Schering-Plough Tries to Deal Its Way to Top
March 13, 2007 | Mr. Hassan yesterday pulled the trigger on a $14.4 billion acquisition of Organon BioSciences NV, a Dutch maker of women's health products such as infertility and contraception drugs. The deal is intended to propel Schering-Plough, long an industry also-ran, back into the pharmaceutical big leagues and fill gaps in the company's thin pipeline of new drugs. Story in The Wall Street Journal (sub. req.)
Feeds